{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:02Z","timestamp":1790745182703,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"crossref","award":["MGU0466"],"award-info":[{"award-number":["MGU0466"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a positive swab test result for SARS-CoV-2 prior to enrolment. Information on 88 potential sociodemographic, behavioural, nutritional, clinical and pharmacological risk factors was obtained through online questionnaires, and combined IgG\/IgA\/IgM responses to SARS-CoV-2 spike glycoprotein were determined in dried blood spots obtained between November 6, 2020, and April 18, 2021. We used logistic and linear regression to estimate adjusted odds ratios (aORs) and adjusted geometric mean ratios (aGMRs) for potential determinants of SARS-CoV-2 seropositivity (all participants) and antibody titres (seropositive participants only), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of\u00a011,130 participants,\u00a01696 (15.2%) were seropositive. Factors independently associated with \u00a0higher risk of SARS-CoV-2 seropositivity included frontline health\/care occupation (aOR 1.86, 95% CI 1.48\u20132.33), international travel (1.20, 1.07\u20131.35), number of visits to shops and other indoor public places (\u2265\u20095 vs. 0\/week: 1.29, 1.06\u20131.57, P-trend\u2009=\u20090.01), body mass index (BMI) \u2265\u200925 vs.\u2009&lt;\u200925\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (1.24, 1.11\u20131.39), South Asian vs. White ethnicity (1.65, 1.10\u20132.49) and alcohol consumption \u226515 vs. 0\u2009units\/week (1.23, 1.04\u20131.46). Light physical exercise associated with \u00a0lower risk (0.80, 0.70\u20130.93, for \u2265\u200910 vs. 0\u20134\u2009h\/week). Among seropositive participants, higher titres of anti-Spike antibodies associated with factors including BMI \u2265\u200930 vs.\u2009&lt;\u200925\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (aGMR 1.10, 1.02\u20131.19), South Asian vs. White ethnicity (1.22, 1.04\u20131.44), frontline health\/care occupation (1.24, 95% CI 1.11\u20131.39), international travel (1.11, 1.05\u20131.16) and number of visits to shops and other indoor public places (\u2265\u20095 vs. 0\/week: 1.12, 1.02\u20131.23, P-trend\u2009=\u20090.01); these associations were not substantially attenuated by adjustment for COVID-19 disease severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher alcohol consumption and lower light physical exercise represent new modifiable risk factors for SARS-CoV-2 infection. Recognised associations between South Asian ethnic origin and obesity and higher risk of SARS-CoV-2 seropositivity were independent of other sociodemographic, behavioural, nutritional, clinical, and pharmacological factors investigated. Among seropositive participants, higher titres of anti-Spike antibodies in people of South Asian ancestry and in obese people were not explained by greater COVID-19 disease severity in these groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02286-4","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:02:27Z","timestamp":1645477347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-3665","authenticated-orcid":false,"given":"Mohammad","family":"Talaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-5569","authenticated-orcid":false,"given":"Sian","family":"Faustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-1945","authenticated-orcid":false,"given":"David A.","family":"Jolliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-9276","authenticated-orcid":false,"given":"Giulia","family":"Vivaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Perdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Maltby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola M.","family":"Bigogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-4545","authenticated-orcid":false,"given":"Jane","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-1008","authenticated-orcid":false,"given":"Gwyneth A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5225-000X","authenticated-orcid":false,"given":"Ronan A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-8167","authenticated-orcid":false,"given":"Frank","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-3056","authenticated-orcid":false,"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-1299","authenticated-orcid":false,"given":"Alex G.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-8691","authenticated-orcid":false,"given":"Seif O.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-1721","authenticated-orcid":false,"given":"Adrian R.","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"2286_CR1","unstructured":"Johns Hopkins University. Coronavirus resource center. 2021. https:\/\/coronavirus.jhu.edu\/ (accessed Sept 17, 2021)."},{"key":"2286_CR2","unstructured":"Tracking covid-19 excess deaths across countries. The Economist; 2021. Available from: https:\/\/www.economist.com\/graphic-detail\/coronavirus-excess-deathstracker.Accessed 10\u00a0Sept 2021."},{"key":"2286_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2147\/IJGM.S305990","volume":"14","author":"S Aung","year":"2021","unstructured":"Aung S, Vittinghoff E, Nah G, et al. Characteristics and behaviors associated with prevalent SARS-CoV-2 infection. Int J Gen Med. 2021;14:1063\u20137.","journal-title":"Int J Gen Med"},{"issue":"5","key":"2286_CR4","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/ije\/dyaa134","volume":"49","author":"M Chadeau-Hyam","year":"2020","unstructured":"Chadeau-Hyam M, Bodinier B, Elliott J, et al. Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data. Int J Epidemiol. 2020;49(5):1454\u201367.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2286_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12939-020-01242-z","volume":"19","author":"Y Rozenfeld","year":"2020","unstructured":"Rozenfeld Y, Beam J, Maier H, et al. A model of disparities: risk factors associated with COVID-19 infection. Int J Equity Health. 2020;19(1):126.","journal-title":"Int J Equity Health"},{"issue":"1","key":"2286_CR6","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1038\/s41467-020-19478-2","volume":"11","author":"GJ Griffith","year":"2020","unstructured":"Griffith GJ, Morris TT, Tudball MJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749.","journal-title":"Nat Commun"},{"key":"2286_CR7","unstructured":"Our World in Data. COVID-19 testing policies. https:\/\/ourworldindata.org\/grapher\/covid-19-testing-policy. Accessed 14\u00a0Oct\u00a02021."},{"issue":"6","key":"2286_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/v13061025","volume":"13","author":"BA Desimmie","year":"2021","unstructured":"Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights into SARS-CoV-2 persistence and its relevance. Viruses. 2021;13(6):1025.","journal-title":"Viruses"},{"key":"2286_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijid.2021.07.003","volume":"109","author":"F Rovida","year":"2021","unstructured":"Rovida F, Cassaniti I, Percivalle E, et al. Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- a retrospective observational case-controlled study. Int J Infect Dis. 2021;109:199\u2013202.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"2286_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/00220345211020270","volume":"100","author":"AM Shields","year":"2021","unstructured":"Shields AM, Faustini SE, Kristunas CA, et al. COVID-19: seroprevalence and vaccine responses in UK dental care professionals. J Dental Res. 2021;100(11):1220\u20137.","journal-title":"J Dental Res"},{"issue":"5","key":"2286_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/ije\/dyab110","volume":"50","author":"F Carrat","year":"2021","unstructured":"Carrat F, de Lamballerie X, Rahib D, et al. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Int J Epidemiol. 2021;50(5):1458\u201372.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2286_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41467-021-21237-w","volume":"12","author":"H Ward","year":"2021","unstructured":"Ward H, Atchison C, Whitaker M, et al. SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021;12(1):905.","journal-title":"Nat Commun"},{"issue":"3","key":"2286_CR13","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1093\/cid\/ciab004","volume":"73","author":"SF Lumley","year":"2021","unstructured":"Lumley SF, Wei J, O'Donnell D, et al. The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers. Clin Infect Dis. 2021;73(3):e699\u2013709.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2286_CR14","doi-asserted-by":"publisher","first-page":"e043584","DOI":"10.1136\/bmjopen-2020-043584","volume":"11","author":"JE Ebinger","year":"2021","unstructured":"Ebinger JE, Botwin GJ, Albert CM, et al. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ Open. 2021;11(2):e043584.","journal-title":"BMJ Open"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"113046","DOI":"10.1016\/j.jim.2021.113046","volume":"494","author":"AM Cook","year":"2021","unstructured":"Cook AM, Faustini SE, Williams LJ, et al. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients. J Immunol Methods. 2021;494:113046.","journal-title":"J Immunol Methods"},{"key":"2286_CR16","doi-asserted-by":"publisher","unstructured":"Holt H, Talaei M, Greenig M, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 2021.\u00a0https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217487. Online ahead of print.","DOI":"10.1136\/thoraxjnl-2021-217487"},{"issue":"6501","key":"2286_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","volume":"369","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369(6501):330\u20133.","journal-title":"Science"},{"issue":"6483","key":"2286_CR18","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20133.","journal-title":"Science"},{"issue":"1","key":"2286_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology"},{"issue":"7","key":"2286_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","volume":"26","author":"C Menni","year":"2020","unstructured":"Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037\u201340.","journal-title":"Nat Med"},{"issue":"2","key":"2286_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ije\/dyaa277","volume":"50","author":"JF Varona","year":"2021","unstructured":"Varona JF, Madurga R, Pe\u00f1alver F, et al. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain. Int J Epidemiol. 2021;50(2):400\u20139.","journal-title":"Int J Epidemiol"},{"issue":"10286","key":"2286_CR22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(21)00634-6","volume":"397","author":"R Mathur","year":"2021","unstructured":"Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711\u201324.","journal-title":"Lancet"},{"issue":"4","key":"2286_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.dsx.2020.04.050","volume":"14","author":"CE Hastie","year":"2020","unstructured":"Hastie CE, Mackay DF, Ho F, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561\u20135.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"2286_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12916-020-01640-8","volume":"18","author":"CL Niedzwiedz","year":"2020","unstructured":"Niedzwiedz CL, O'Donnell CA, Jani BD, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160.","journal-title":"BMC Med"},{"key":"2286_CR25","first-page":"642723","volume":"8","author":"N Choudhry","year":"2021","unstructured":"Choudhry N, Drysdale K, Usai C, et al. Disparities of SARS-CoV-2 nucleoprotein-specific IgG in healthcare workers in East London. UK Front Med (Lausanne). 2021;8:642723.","journal-title":"UK Front Med (Lausanne)"},{"issue":"1-2","key":"2286_CR26","first-page":"97","volume":"33","author":"PE Molina","year":"2010","unstructured":"Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S. Focus on: alcohol and the immune system. Alcohol Res Health. 2010;33(1-2):97\u2013108.","journal-title":"Alcohol Res Health"},{"key":"2286_CR27","doi-asserted-by":"publisher","unstructured":"Jones AW, Davison G. Exercise, Immunity, and Illness. Muscle Exerc Physiol. 2019:317\u201344.\u00a0https:\/\/doi.org\/10.1016\/B978-0-12-814593-7.00015-3.","DOI":"10.1016\/B978-0-12-814593-7.00015-3"},{"issue":"9","key":"2286_CR28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S1473-3099(20)30371-6","volume":"20","author":"S de Lusignan","year":"2020","unstructured":"de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034\u201342.","journal-title":"Lancet Infect Dis"},{"key":"2286_CR29","doi-asserted-by":"publisher","unstructured":"Fan VS, Dominitz JA, Eastment MC, et al. Risk factors for testing positive for SARS-CoV-2 in a national US healthcare system.\u00a0Clin Infect Dis. 2021;73(9):e3085\u2013e3094.\u00a0https:\/\/doi.org\/10.1093\/cid\/ciaa1624.","DOI":"10.1093\/cid\/ciaa1624"},{"key":"2286_CR30","doi-asserted-by":"publisher","unstructured":"Horton DB, Barrett ES, Roy J, et al. Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study.\u00a0J Infect Dis. 2021;224(8):1345\u20131356.\u00a0https:\/\/doi.org\/10.1093\/infdis\/jiab411.","DOI":"10.1093\/infdis\/jiab411"},{"issue":"10","key":"2286_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2286_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/nu12010236","volume":"12","author":"AF Gombart","year":"2020","unstructured":"Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236.","journal-title":"Nutrients"},{"issue":"3","key":"2286_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","volume":"19","author":"M Trebak","year":"2019","unstructured":"Trebak M, Kinet J-P. Calcium signalling in T cells. Nat Rev Immunol. 2019;19(3):154\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2286_CR34","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.isci.2021.102646","volume":"24","author":"PV Coyle","year":"2021","unstructured":"Coyle PV, Chemaitelly H, Ben Hadj Kacem MA, et al. SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals. iScience. 2021;24(6):102646.","journal-title":"iScience"},{"issue":"3","key":"2286_CR35","doi-asserted-by":"publisher","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang HS, Costa V, Racine-Brzostek SE, et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open. 2021;4(3):e214302.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2286_CR36","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3201\/eid2612.203309","volume":"26","author":"GL Morley","year":"2020","unstructured":"Morley GL, Taylor S, Jossi S, et al. Sensitive detection of SARS-CoV-2-specific antibodies in dried blood spot samples. Emerg Infect Dis. 2020;26(12):2970\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2286_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/sextrans-2020-054692","volume":"97","author":"M Page","year":"2021","unstructured":"Page M, Atabani S, Arumainayagam J, Wilson S, Hartland D, Taylor S. Are all blood-based postal sampling kits the same? A comparative service evaluation of the performance of dried blood spot and mini tube sample collection systems for postal HIV and syphilis testing. Sex Transm Infect. 2021;97(3):209.","journal-title":"Sex Transm Infect"},{"key":"2286_CR38","unstructured":"COVID-19 Infection Survey: methods and further information. 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/methodologies\/covid19infectionsurveypilotmethodsandfurtherinformation#processing-swabs-and-blood-samples. Accessed 24\u00a0Sept\u00a02021."},{"issue":"4","key":"2286_CR39","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/ije\/dyt103","volume":"42","author":"L Richiardi","year":"2013","unstructured":"Richiardi L, Pizzi C, Pearce N. Commentary: Representativeness is usually not necessary and often should be avoided. Int J Epidemiol. 2013;42(4):1018\u201322.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02286-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02286-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02286-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:03:28Z","timestamp":1645477408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02286-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02286-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.02.21265767","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Leicester South Research Ethics Committee (ref 20\/EM\/0117). All participants provided informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS declares receipt of payments from Reach plc for news stories written about recruitment to, and findings of, the COVIDENCE UK study. AS is a member of the Scottish Government Chief Medical Officer\u2019s COVID-19 Advisory Group and its Standing Committee on Pandemics. He is also a member of the UK Government\u2019s NERVTAG\u2019s Risk Stratification Subgroup. ARM declares receipt of funding in the last 36\u2009months to support vitamin D research from the following companies who manufacture or sell vitamin D supplements: Pharma Nord Ltd, DSM Nutritional Products Ltd, Thornton & Ross Ltd and Hyphens Pharma Ltd. ARM also declares support for attending meetings from the following companies who manufacture or sell vitamin D supplements: Pharma Nord Ltd and Abiogen Pharma Ltd. ARM also declares participation on the Data and Safety Monitoring Board for the Chair, DSMB, VITALITY trial (Vitamin D for Adolescents with HIV to reduce musculoskeletal morbidity and immunopathology). ARM also declares unpaid work as a Programme Committee member for the Vitamin D Workshop. ARM also declares receipt of vitamin D capsules for clinical trial use from Pharma Nord Ltd, Synergy Biologics Ltd and Cytoplan Ltd. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}